lobbying_activities: 3246369

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3246369	7f2662d7-c51e-4166-88c6-b9fd9d7bfb18	Q3	E3 STRATEGIC CONSULTING GROUP	401104104	PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION	2024	third_quarter	PHA	Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2024-10-17T21:16:46-04:00